{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# First implementation of a GNN (GCN)\n",
    "In this notebook, we build the graph from an initial dataframe, and we execute the first implementation of our GNN, which contains 1 convolutive layer and 1 fully-connected layer.\n",
    "\n",
    "## Notebook plan : \n",
    "1. Building the graph\n",
    "2. Building the GCN\n",
    "3. Train the GCN"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from models.BuildGraph import BuildGraph\n",
    "from models.GCN import GCN\n",
    "from manage.GCNTrainTestManager import GCNTrainTestManager\n",
    "import torch"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Building the graph\n",
    "Here, we split the patients by tumour type. We merge tumour types if they contain only 1 patient."
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Reading the dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Anonymous ID</th>\n",
       "      <th>EGA ID</th>\n",
       "      <th>Tumour type</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Line of therapy</th>\n",
       "      <th>Immunotherapy regimen</th>\n",
       "      <th>Cohort</th>\n",
       "      <th>Reason for discontinuation</th>\n",
       "      <th>Best response</th>\n",
       "      <th>Age at advanced disease diagnosis</th>\n",
       "      <th>...</th>\n",
       "      <th>Alive_0</th>\n",
       "      <th>Time to progression (days)</th>\n",
       "      <th>Progression_1</th>\n",
       "      <th>Clinical benefit</th>\n",
       "      <th>CD8+ T cell score</th>\n",
       "      <th>Exome mut per mb</th>\n",
       "      <th>Genome mut per mb</th>\n",
       "      <th>CD274 expression</th>\n",
       "      <th>M1M2 expression</th>\n",
       "      <th>Lymph related</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>14891</td>\n",
       "      <td>EGAD00001001961</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>8</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Mixed</td>\n",
       "      <td>45</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>179</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.351869</td>\n",
       "      <td>11.095310</td>\n",
       "      <td>23.0729</td>\n",
       "      <td>4.1689</td>\n",
       "      <td>55.51575</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>18624</td>\n",
       "      <td>EGAD00001002047</td>\n",
       "      <td>AECA</td>\n",
       "      <td>F</td>\n",
       "      <td>10</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>47</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>148</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.071464</td>\n",
       "      <td>3.876336</td>\n",
       "      <td>5.4552</td>\n",
       "      <td>0.7910</td>\n",
       "      <td>9.32352</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>21392</td>\n",
       "      <td>EGAD00001002544</td>\n",
       "      <td>OV</td>\n",
       "      <td>F</td>\n",
       "      <td>6</td>\n",
       "      <td>Monalizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>57</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>79</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.040394</td>\n",
       "      <td>2.415688</td>\n",
       "      <td>4.1274</td>\n",
       "      <td>4.0377</td>\n",
       "      <td>50.12008</td>\n",
       "      <td>Lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>21516</td>\n",
       "      <td>EGAD00001002546</td>\n",
       "      <td>SKCM</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Ipilimumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Not evaluable</td>\n",
       "      <td>29</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.052774</td>\n",
       "      <td>6.235845</td>\n",
       "      <td>11.4871</td>\n",
       "      <td>0.6006</td>\n",
       "      <td>1.58550</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>22186</td>\n",
       "      <td>EGAD00001001966</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>4</td>\n",
       "      <td>Atezolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>52</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>80</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.009323</td>\n",
       "      <td>4.606660</td>\n",
       "      <td>7.1503</td>\n",
       "      <td>1.8234</td>\n",
       "      <td>38.42695</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>39280</td>\n",
       "      <td>EGAD00001004933</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>M</td>\n",
       "      <td>2</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Physician Assessed SD</td>\n",
       "      <td>60</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>401</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.695396</td>\n",
       "      <td>84.998501</td>\n",
       "      <td>96.4079</td>\n",
       "      <td>8.4768</td>\n",
       "      <td>86.62561</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>37899</td>\n",
       "      <td>EGAD00001005838</td>\n",
       "      <td>CHOL</td>\n",
       "      <td>F</td>\n",
       "      <td>2</td>\n",
       "      <td>Nivolumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Death</td>\n",
       "      <td>Physician assessed PR</td>\n",
       "      <td>38</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>96</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.818233</td>\n",
       "      <td>2.247151</td>\n",
       "      <td>2.7416</td>\n",
       "      <td>11.2704</td>\n",
       "      <td>47.97376</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>37775</td>\n",
       "      <td>EGAD00001004934</td>\n",
       "      <td>HNSC</td>\n",
       "      <td>M</td>\n",
       "      <td>1</td>\n",
       "      <td>Avelumab/OX40 agonist PF-04518600</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Stable disease</td>\n",
       "      <td>69</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>69</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.018982</td>\n",
       "      <td>3.848247</td>\n",
       "      <td>5.8036</td>\n",
       "      <td>8.7136</td>\n",
       "      <td>5.13403</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>38313</td>\n",
       "      <td>EGAD00001005844</td>\n",
       "      <td>ACC</td>\n",
       "      <td>F</td>\n",
       "      <td>3</td>\n",
       "      <td>Avelumab/Debio1143 (SMAC mimetic)</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Toxicity</td>\n",
       "      <td>Partial response</td>\n",
       "      <td>34</td>\n",
       "      <td>...</td>\n",
       "      <td>1</td>\n",
       "      <td>51</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>5.617878</td>\n",
       "      <td>7.7940</td>\n",
       "      <td>0.0688</td>\n",
       "      <td>0.51364</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>38207</td>\n",
       "      <td>EGAD00001005850</td>\n",
       "      <td>LUNG</td>\n",
       "      <td>F</td>\n",
       "      <td>1</td>\n",
       "      <td>Pembrolizumab</td>\n",
       "      <td>Naive</td>\n",
       "      <td>Progression</td>\n",
       "      <td>Physician assessed SD</td>\n",
       "      <td>50</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>104</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0.110416</td>\n",
       "      <td>33.763449</td>\n",
       "      <td>53.2769</td>\n",
       "      <td>23.8818</td>\n",
       "      <td>11.22022</td>\n",
       "      <td>Non-lymph related</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>82 rows Ã— 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "    Anonymous ID           EGA ID Tumour type Sex Line of therapy   \n",
       "0          14891  EGAD00001001961        LUNG   F               8  \\\n",
       "1          18624  EGAD00001002047        AECA   F              10   \n",
       "2          21392  EGAD00001002544          OV   F               6   \n",
       "3          21516  EGAD00001002546        SKCM   F               3   \n",
       "4          22186  EGAD00001001966        LUNG   F               4   \n",
       "..           ...              ...         ...  ..             ...   \n",
       "92         39280  EGAD00001004933        LUNG   M               2   \n",
       "94         37899  EGAD00001005838        CHOL   F               2   \n",
       "95         37775  EGAD00001004934        HNSC   M               1   \n",
       "96         38313  EGAD00001005844         ACC   F               3   \n",
       "97         38207  EGAD00001005850        LUNG   F               1   \n",
       "\n",
       "                Immunotherapy regimen Cohort Reason for discontinuation   \n",
       "0                           Nivolumab  Naive                Progression  \\\n",
       "1                           Nivolumab  Naive                Progression   \n",
       "2                         Monalizumab  Naive                Progression   \n",
       "3                          Ipilimumab  Naive                      Death   \n",
       "4                        Atezolizumab  Naive                Progression   \n",
       "..                                ...    ...                        ...   \n",
       "92                      Pembrolizumab  Naive                   Toxicity   \n",
       "94                          Nivolumab  Naive                      Death   \n",
       "95  Avelumab/OX40 agonist PF-04518600  Naive                Progression   \n",
       "96  Avelumab/Debio1143 (SMAC mimetic)  Naive                   Toxicity   \n",
       "97                      Pembrolizumab  Naive                Progression   \n",
       "\n",
       "            Best response  Age at advanced disease diagnosis  ...  Alive_0   \n",
       "0                   Mixed                                 45  ...        1  \\\n",
       "1          Stable disease                                 47  ...        1   \n",
       "2   Physician assessed SD                                 57  ...        1   \n",
       "3           Not evaluable                                 29  ...        1   \n",
       "4          Stable disease                                 52  ...        1   \n",
       "..                    ...                                ...  ...      ...   \n",
       "92  Physician Assessed SD                                 60  ...        1   \n",
       "94  Physician assessed PR                                 38  ...        1   \n",
       "95         Stable disease                                 69  ...        1   \n",
       "96       Partial response                                 34  ...        1   \n",
       "97  Physician assessed SD                                 50  ...        0   \n",
       "\n",
       "    Time to progression (days)  Progression_1  Clinical benefit   \n",
       "0                          179              1                 0  \\\n",
       "1                          148              1                 0   \n",
       "2                           79              1                 0   \n",
       "3                           11              0                 0   \n",
       "4                           80              1                 0   \n",
       "..                         ...            ...               ...   \n",
       "92                         401              0                 1   \n",
       "94                          96              0                 0   \n",
       "95                          69              1                 0   \n",
       "96                          51              1                 0   \n",
       "97                         104              1                 0   \n",
       "\n",
       "    CD8+ T cell score  Exome mut per mb  Genome mut per mb  CD274 expression   \n",
       "0            0.351869         11.095310            23.0729            4.1689  \\\n",
       "1            0.071464          3.876336             5.4552            0.7910   \n",
       "2            0.040394          2.415688             4.1274            4.0377   \n",
       "3            0.052774          6.235845            11.4871            0.6006   \n",
       "4            0.009323          4.606660             7.1503            1.8234   \n",
       "..                ...               ...                ...               ...   \n",
       "92           0.695396         84.998501            96.4079            8.4768   \n",
       "94           0.818233          2.247151             2.7416           11.2704   \n",
       "95           0.018982          3.848247             5.8036            8.7136   \n",
       "96           0.000000          5.617878             7.7940            0.0688   \n",
       "97           0.110416         33.763449            53.2769           23.8818   \n",
       "\n",
       "    M1M2 expression      Lymph related  \n",
       "0          55.51575  Non-lymph related  \n",
       "1           9.32352  Non-lymph related  \n",
       "2          50.12008      Lymph related  \n",
       "3           1.58550  Non-lymph related  \n",
       "4          38.42695  Non-lymph related  \n",
       "..              ...                ...  \n",
       "92         86.62561  Non-lymph related  \n",
       "94         47.97376  Non-lymph related  \n",
       "95          5.13403  Non-lymph related  \n",
       "96          0.51364  Non-lymph related  \n",
       "97         11.22022  Non-lymph related  \n",
       "\n",
       "[82 rows x 21 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_excel('data/Supplemental-table1.xlsx')\n",
    "df = df.loc[df[\"Cohort\"] == \"Naive\"]\n",
    "df[\"Clinical benefit\"] = np.where(df[\"Clinical benefit\"]==\"DCB\",1,0)\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "buildgraph = BuildGraph(df)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Compute the adjacency matrix"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[0., 0., 0., ..., 0., 0., 1.],\n",
       "       [0., 0., 0., ..., 0., 0., 0.],\n",
       "       [0., 0., 0., ..., 0., 0., 0.],\n",
       "       ...,\n",
       "       [0., 0., 0., ..., 0., 0., 0.],\n",
       "       [0., 0., 0., ..., 0., 0., 0.],\n",
       "       [1., 0., 0., ..., 0., 0., 0.]])"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "buildgraph.compute_adjacency_matrix(\"Tumour type\")\n",
    "display(buildgraph.A)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Build the graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "features_label = [\"CD8+ T cell score\",\"Exome mut per mb\"]\n",
    "y_label = \"Clinical benefit\"\n",
    "\n",
    "buildgraph.create_graph(features_label, y_label)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Show the graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x700 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "buildgraph.show_graph(\"Graph with split per tumour type\",\"tumour-type.png\")"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Building the GCN"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Formatting data\n",
    "We convert the Networkx graph to a PyTorch Geometric graph."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "from torch_geometric.utils.convert import from_networkx\n",
    "\n",
    "pyg_graph = from_networkx(buildgraph.G)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Instanciate the GCN"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "GCN(\n",
      "  (conv): GCNConv(2, 2)\n",
      "  (linear): Linear(in_features=2, out_features=1, bias=True)\n",
      ")\n"
     ]
    }
   ],
   "source": [
    "model = GCN(2)\n",
    "print(model)"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 3. Training the GCN"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Define loss function and optimizer and instanciate the trainer\n",
    "\n",
    "loss_function = torch.nn.BCELoss() \n",
    "optimizer = torch.optim.Adam(model.parameters(), lr=0.01)\n",
    "trainer = GCNTrainTestManager(model, pyg_graph, loss_function, optimizer)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Epoch 1 of 100\n",
      "Epoch 2 of 100\n",
      "Epoch 3 of 100\n",
      "Epoch 4 of 100\n",
      "Epoch 5 of 100\n",
      "Epoch 6 of 100\n",
      "Epoch 7 of 100\n",
      "Epoch 8 of 100\n",
      "Epoch 9 of 100\n",
      "Epoch 10 of 100\n",
      "Epoch 11 of 100\n",
      "Epoch 12 of 100\n",
      "Epoch 13 of 100\n",
      "Epoch 14 of 100\n",
      "Epoch 15 of 100\n",
      "Epoch 16 of 100\n",
      "Epoch 17 of 100\n",
      "Epoch 18 of 100\n",
      "Epoch 19 of 100\n",
      "Epoch 20 of 100\n",
      "Epoch 21 of 100\n",
      "Epoch 22 of 100\n",
      "Epoch 23 of 100\n",
      "Epoch 24 of 100\n",
      "Epoch 25 of 100\n",
      "Epoch 26 of 100\n",
      "Epoch 27 of 100\n",
      "Epoch 28 of 100\n",
      "Epoch 29 of 100\n",
      "Epoch 30 of 100\n",
      "Epoch 31 of 100\n",
      "Epoch 32 of 100\n",
      "Epoch 33 of 100\n",
      "Epoch 34 of 100\n",
      "Epoch 35 of 100\n",
      "Epoch 36 of 100\n",
      "Epoch 37 of 100\n",
      "Epoch 38 of 100\n",
      "Epoch 39 of 100\n",
      "Epoch 40 of 100\n",
      "Epoch 41 of 100\n",
      "Epoch 42 of 100\n",
      "Epoch 43 of 100\n",
      "Epoch 44 of 100\n",
      "Epoch 45 of 100\n",
      "Epoch 46 of 100\n",
      "Epoch 47 of 100\n",
      "Epoch 48 of 100\n",
      "Epoch 49 of 100\n",
      "Epoch 50 of 100\n",
      "Epoch 51 of 100\n",
      "Epoch 52 of 100\n",
      "Epoch 53 of 100\n",
      "Epoch 54 of 100\n",
      "Epoch 55 of 100\n",
      "Epoch 56 of 100\n",
      "Epoch 57 of 100\n",
      "Epoch 58 of 100\n",
      "Epoch 59 of 100\n",
      "Epoch 60 of 100\n",
      "Epoch 61 of 100\n",
      "Epoch 62 of 100\n",
      "Epoch 63 of 100\n",
      "Epoch 64 of 100\n",
      "Epoch 65 of 100\n",
      "Epoch 66 of 100\n",
      "Epoch 67 of 100\n",
      "Epoch 68 of 100\n",
      "Epoch 69 of 100\n",
      "Epoch 70 of 100\n",
      "Epoch 71 of 100\n",
      "Epoch 72 of 100\n",
      "Epoch 73 of 100\n",
      "Epoch 74 of 100\n",
      "Epoch 75 of 100\n",
      "Epoch 76 of 100\n",
      "Epoch 77 of 100\n",
      "Epoch 78 of 100\n",
      "Epoch 79 of 100\n",
      "Epoch 80 of 100\n",
      "Epoch 81 of 100\n",
      "Epoch 82 of 100\n",
      "Epoch 83 of 100\n",
      "Epoch 84 of 100\n",
      "Epoch 85 of 100\n",
      "Epoch 86 of 100\n",
      "Epoch 87 of 100\n",
      "Epoch 88 of 100\n",
      "Epoch 89 of 100\n",
      "Epoch 90 of 100\n",
      "Epoch 91 of 100\n",
      "Epoch 92 of 100\n",
      "Epoch 93 of 100\n",
      "Epoch 94 of 100\n",
      "Epoch 95 of 100\n",
      "Epoch 96 of 100\n",
      "Epoch 97 of 100\n",
      "Epoch 98 of 100\n",
      "Epoch 99 of 100\n",
      "Epoch 100 of 100\n",
      "End of training.\n"
     ]
    }
   ],
   "source": [
    "trainer.train(n_epochs=100)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.6"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
